1 day Ago Solskin Becton Dickinson ( NYSE: BDX ) is in talks with rivals including Thermo Fisher ( TMO ) and Danaher ( DHR ) over plans to divest its $21 billion life sciences business. The medical device maker has started management meetings with interested parties in recent weeks, according to.
